Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07459244 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ECG Findings in Methamphetamine Use

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 months later Apr 6, 2026 → Nov 2, 2026
See other at-risk trials from Elazığ Mental Health and Diseases Hospital

Record History

  1. Primary completion pushed from Apr 6, 2026 to Nov 2, 2026
    • Study completion pushed from May 11, 2026 to Dec 22, 2026
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This prospective cohort study aims to examine and compare electrocardiogram (ECG) parameters in subjects diagnosed with Methamphetamine Use Disorder (MUD) and Methamphetamine-Induced Psychotic Disorder (MP) during inpatient psychiatric treatment. ECG findings at hospital admission and during remission prior to discharge will be evaluated and compared between groups. The study also aims to determine whether methamphetamine-induced psychosis is associated with greater ECG abnormalities and increased cardiac risk compared to methamphetamine use without psychosis.
Trial Details
NCT Number NCT07459244
Lead Sponsor Elazığ Mental Health and Diseases Hospital
Conditions
(from sponsor)		 Methamphetamine Use Disorder, Methamphetamine Induced Psychosis
Enrollment 240 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov